|
1
|
Bridge F, Brotherton JML, Foong Y, Butzkueven H, Jokubaitis VG, Van der Walt A. Risk of cervical pre-cancer and cancer in women with multiple sclerosis exposed to high efficacy disease modifying therapies. Front Neurol 2023; 14:1119660. [PMID: 36846149 PMCID: PMC9950275 DOI: 10.3389/fneur.2023.1119660] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/09/2022] [Accepted: 01/24/2023] [Indexed: 02/12/2023] Open
Abstract
There is a growing need to better understand the risk of malignancy in the multiple sclerosis (MS) population, particularly given the relatively recent and widespread introduction of immunomodulating disease modifying therapies (DMTs). Multiple sclerosis disproportionately affects women, and the risk of gynecological malignancies, specifically cervical pre-cancer and cancer, are of particular concern. The causal relationship between persistent human papillomavirus (HPV) infection and cervical cancer has been definitively established. To date, there is limited data on the effect of MS DMTs on the risk of persistent HPV infection and subsequent progression to cervical pre-cancer and cancer. This review evaluates the risk of cervical pre-cancer and cancer in women with MS, including the risk conferred by DMTs. We examine additional factors, specific to the MS population, that alter the risk of developing cervical cancer including participation in HPV vaccination and cervical screening programs.
Collapse
Affiliation(s)
- Francesca Bridge
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia,Department of Neurology, Alfred Health, Melbourne, VIC, Australia,*Correspondence: Francesca Bridge ✉
| | - Julia M. L. Brotherton
- Australian Centre for the Prevention of Cervical Cancer (Formerly Victorian Cytology Service), Carlton South, VIC, Australia,Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, VIC, Australia
| | - Yi Foong
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia,Department of Neurology, Alfred Health, Melbourne, VIC, Australia,Department of Neurosciences, Eastern Health, Melbourne, VIC, Australia
| | - Helmut Butzkueven
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia,Department of Neurology, Alfred Health, Melbourne, VIC, Australia
| | - Vilija G. Jokubaitis
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia,Department of Neurology, Alfred Health, Melbourne, VIC, Australia
| | - Anneke Van der Walt
- Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia,Department of Neurology, Alfred Health, Melbourne, VIC, Australia
| |
Collapse
|
|
2
|
Hill D, Lim H, Foong Y, Nelson V, Won K, Lazar M. OR043 Obesity disrupts tissue-protective macrophage populations in the adipose and lung. Ann Allergy Asthma Immunol 2017. [DOI: 10.1016/j.anai.2017.08.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
|
3
|
Foong Y, Aitken D, Humphries D, Laslett L, Pitchford N, Khan H, Abram F, Pelletier J, Martel-Pelletier J, Jin X, Jones G, Winzenberg T. Knee function, pain and magnetic resonance imaging abnormalities in Australian Rules Football players: a cohort study. Intern Med J 2017. [DOI: 10.1111/imj.5_13463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Y Foong
- Menzies Institute for Medical Research; University of Tasmania; Hobart Tasmania Australia
- Royal Hobart Hospital; Hobart Tasmania Australia
| | - D Aitken
- Menzies Institute for Medical Research; University of Tasmania; Hobart Tasmania Australia
| | - D Humphries
- The Sports Medicine Practice; Hobart Tasmania Australia
| | - L Laslett
- Menzies Institute for Medical Research; University of Tasmania; Hobart Tasmania Australia
| | - N Pitchford
- Institute of Sport Exercise and Active Living (ISEAL); Victoria, University Footscray Park Campus Footscray Victoria Australia
| | - H Khan
- Menzies Institute for Medical Research; University of Tasmania; Hobart Tasmania Australia
| | - F Abram
- Medical Imaging Research & Development; ArthroLab Inc.; Montreal Quebec Canada
| | - J Pelletier
- Osteoarthritis Research Unit; University of Montreal Hospital Research Centre (CRCHUM); Montreal Quebec Canada
| | - J Martel-Pelletier
- Osteoarthritis Research Unit; University of Montreal Hospital Research Centre (CRCHUM); Montreal Quebec Canada
| | - X Jin
- Australian Institute of Health Innovation; Macquarie University; Sydney Australia
| | - G Jones
- Menzies Institute for Medical Research; University of Tasmania; Hobart Tasmania Australia
| | - T Winzenberg
- Menzies Institute for Medical Research; University of Tasmania; Hobart Tasmania Australia
- Faculty of Health; University of Tasmania; Hobart Tasmania Australia
| |
Collapse
|